Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists
HC Huang, DB Reitz, TS Chamberlain…
Index: Huang, Horng-Chih; Reitz, David B.; Chamberlain, Timothy S.; Olins, Gillian M.; Corpus. Valerie M.; et al. Journal of Medicinal Chemistry, 1993 , vol. 36, # 15 p. 2172 - 2181
Full Text: HTML
Citation Number: 24
Abstract
2, 5-Dibutyl-2, 4-dihydro-4-[[2-(1H-tetrazol-5-~ 1)[l, l'-biphenyl]-4'-yllmethyl]-3H-1, 2, 4-triazol- 3-one, SC-51316, was synthesized as a potent and orally active angiotensin I1 (AII) receptor antagonist with a long duration of action. To explore the lipophilic pocket in the AI1 receptor interacting with the substituent at the 2-position of triazolone-based antagonists, a series of compounds were prepared and evaluated for receptor binding affinity and antagonism of ...
Related Articles:
[Chao, Shu-Jun; Hui, Xin-Ping; Li, Shuo; Qiu, Zao-Zao; Xu, Peng-Fei; Zhang, Zi-Yi; Wang, Qin; Guan, Zuo-Wu Journal of the Chinese Chemical Society, 2005 , vol. 52, # 3 p. 539 - 544]
Potent, orally active imidazo [4, 5-b] pyridine-based angiotensin II receptor antagonists
[Mantlo, Nathan B.; Chakravarty, Prasun K.; Ondeyka, Debra L.; Siegl, Peter K. S.; Chang, Raymond S.; et al. Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2919 - 2922]
Potent, orally active imidazo [4, 5-b] pyridine-based angiotensin II receptor antagonists
[Mantlo, Nathan B.; Chakravarty, Prasun K.; Ondeyka, Debra L.; Siegl, Peter K. S.; Chang, Raymond S.; et al. Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2919 - 2922]
[Carini, David J.; Duncia, John V.; Aldrich, Paul E.; Chiu, Andrew T.; Johnson, Alexander L.; et al. Journal of Medicinal Chemistry, 1991 , vol. 34, # 8 p. 2525 - 2547]
[Carini, David J.; Duncia, John V.; Aldrich, Paul E.; Chiu, Andrew T.; Johnson, Alexander L.; et al. Journal of Medicinal Chemistry, 1991 , vol. 34, # 8 p. 2525 - 2547]